Synthes and DePuy to Merge??

As reported by The Wall Street Journal on Friday and confirmed in a statement by Synthes earlier today by email, Synthes and Depuy have been in talks to potentially merger.

In response to market speculation, Synthes, Inc. (SIX Swiss Exchange: SYST.VX), confirms that it is engaged in discussions with Johnson & Johnson about a potential business combination transaction.  No assurance can be given as to whether, when or on what terms any possible transaction might occur. Synthes does not intend to make any further public statements unless and until a definitive agreement has been reached, or until discussions between the parties have terminated.

This merger would create the world's largest orthopedic device company with an annual output of nearly $9.3 billion dollars. The combined firm would also account for roughly 28% of the overall market followed by #2 Stryker and #3 Zimmer at 14% and 13%.


Check out the various product by Synthes and Depuy.